NASDAQ:OPTN
OptiNose Inc. Stock News
$1.14
+0.130 (+12.87%)
At Close: May 06, 2024
Optinose to Present at the Needham Virtual Healthcare Conference
04:01pm, Thursday, 04'th Apr 2024
YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced tha
OptiNose (OPTN) Reports Q4 Loss, Lags Revenue Estimates
09:16am, Thursday, 07'th Mar 2024
OptiNose (OPTN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.17 per share a year ago.
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
04:40pm, Thursday, 29'th Feb 2024
Conference Call and Webcast to be held March 7, 2024, at 8:00 a.m. Eastern Time Conference Call and Webcast to be held March 7, 2024, at 8:00 a.m. Eastern Time
OptiNose (OPTN) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Tuesday, 24'th Oct 2023
OptiNose (OPTN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Optinose to Present at the 2023 Cantor Global Healthcare Conference
09:01am, Friday, 22'nd Sep 2023
YARDLEY, Pa., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced tha
5 Top-Ranked Stocks With Rising P/E for Solid Returns
09:46am, Thursday, 24'th Aug 2023
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Nektar Therapeutics (NKTR), Energous (WATT), DocuSign (DOCU), OptiNose (OPTN) and Canadian Solar (CSIQ)
OptiNose (OPTN) Q2 Earnings and Revenues Top Estimates
10:01am, Thursday, 10'th Aug 2023
OptiNose (OPTN) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.11 per share. This compares to loss of $0.23 per share a year ago.
OptiNose: The Worst Has Been Avoided (Rating Upgrade)
06:58pm, Tuesday, 01'st Aug 2023
On August 10, OptiNose, one of the leaders in the global chronic rhinosinusitis market, will publish its financial results for the 2nd quarter of 2023. OptiNose's preliminary net revenue for the secon
Optinose to Present at the Jefferies Healthcare Conference
01:00pm, Friday, 02'nd Jun 2023
YARDLEY, Pa., June 02, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that
OptiNose Inc. (OPTN) Q1 2023 Earnings Call Transcript
05:57pm, Thursday, 11'th May 2023
OptiNose Inc. (NASDAQ:OPTN ) Q1 2023 Results Conference Call May 11, 2023 8:00 AM ET Company Participants Jonathan Neely - VP of IR and Business Operations Ramy Mahmoud - CEO and Director Conference C
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
10:40am, Thursday, 11'th May 2023
OptiNose (OPTN) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.31 per share a year ago.
Optinose Announces Reporting Date for First Quarter 2023 Financial Results
04:30pm, Monday, 01'st May 2023
Conference Call and Webcast to be held May 11, 2023, at 8:00 a.m. Eastern Time Conference Call and Webcast to be held May 11, 2023, at 8:00 a.m. Eastern Time
Optinose to Present at the Needham Virtual Healthcare Conference
04:00pm, Wednesday, 12'th Apr 2023
YARDLEY, Pa., April 12, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced tha
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates
09:47am, Tuesday, 07'th Mar 2023
OptiNose (OPTN) delivered earnings and revenue surprises of -6.25% and 3.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results
04:30pm, Tuesday, 28'th Feb 2023
Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern Time Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern Time